Literature DB >> 24070864

Altered sphingoid base profiles predict compromised membrane structure and permeability in atopic dermatitis.

Nicolas Loiseau1, Yasuko Obata, Sam Moradian, Hiromu Sano, Saeko Yoshino, Kenichi Aburai, Kozo Takayama, Kazutami Sakamoto, Walter M Holleran, Peter M Elias, Yoshikazu Uchida.   

Abstract

BACKGROUND: Ceramide hydrolysis by ceramidase in the stratum corneum (SC) yields both sphingoid bases and free fatty acids (FFA). While FFA are key constituents of the lamellar bilayers that mediate the epidermal permeability barrier, whether sphingoid bases influence permeability barrier homeostasis remains unknown. Pertinently, alterations of lipid profile, including ceramide and ceramidase activities occur in atopic dermatitis (AD). OBJECT: We investigated alterations in sphingoid base levels and/or profiles (sphingosine to sphinganine ratio) in the SC of normal vs. AD mice, a model that faithfully replicates human AD, and then whether altered sphingoid base levels and/or profiles influence(s) membrane stability and/or structures.
METHODS: Unilamellar vesicles (LV), incorporating the three major SC lipids (ceramides/FFA/cholesterol) and different ratios of sphingosine/sphinganine, encapsulating carboxyfluorescein, were used as the model of SC lipids. Membrane stability was measured as release of carboxyfluorescein. Thermal analysis of LV was conducted by differential scanning calorimetry (DSC).
RESULTS: LV containing AD levels of sphingosine/sphinganine (AD-LV) displayed altered membrane permeability vs. normal-LV. DSC analyses revealed decreases in orthorhombic structures that form tightly packed lamellar structures in AD-LV.
CONCLUSION: Sphingoid base composition influences lamellar membrane architecture in SC, suggesting that altered sphingoid base profiles could contribute to the barrier abnormality in AD.
Copyright © 2013 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  2,5-carboxyfluorescein; AD; Atopic dermatitis; Barrier; CFC; Cer; Ceramide; DSC; FFA; LV; SC; SDS; Sa; So; Sphingosine; atopic dermatitis; ceramide; differential scanning calorimetry; free fatty acids; sodium dodecyl sulfate; sphinganine; sphingosine; stratum corneum; unilamellar vesicles

Mesh:

Substances:

Year:  2013        PMID: 24070864      PMCID: PMC3866955          DOI: 10.1016/j.jdermsci.2013.08.003

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  53 in total

Review 1.  Structure of the skin barrier and its modulation by vesicular formulations.

Authors:  Joke A Bouwstra; P Loan Honeywell-Nguyen; Gert S Gooris; Maria Ponec
Journal:  Prog Lipid Res       Date:  2003-01       Impact factor: 16.195

2.  The extent of orthorhombic lipid phases in the stratum corneum determines the barrier efficiency of human skin in vivo.

Authors:  Fabienne Damien; Mila Boncheva
Journal:  J Invest Dermatol       Date:  2009-09-03       Impact factor: 8.551

3.  Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis.

Authors:  Y Ohnishi; N Okino; M Ito; S Imayama
Journal:  Clin Diagn Lab Immunol       Date:  1999-01

4.  Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients.

Authors:  Michelle Janssens; Jeroen van Smeden; Gert S Gooris; Wim Bras; Guiseppe Portale; Peter J Caspers; Rob J Vreeken; Thomas Hankemeier; Sanja Kezic; Ron Wolterbeek; Adriana P Lavrijsen; Joke A Bouwstra
Journal:  J Lipid Res       Date:  2012-09-28       Impact factor: 5.922

Review 5.  Epidermal sphingolipids: metabolism, function, and roles in skin disorders.

Authors:  Walter M Holleran; Yutaka Takagi; Yoshikazu Uchida
Journal:  FEBS Lett       Date:  2006-09-01       Impact factor: 4.124

6.  Increased presence of monounsaturated fatty acids in the stratum corneum of human skin equivalents.

Authors:  Varsha S Thakoersing; Jeroen van Smeden; Aat A Mulder; Rob J Vreeken; Abdoelwaheb El Ghalbzouri; Joke A Bouwstra
Journal:  J Invest Dermatol       Date:  2012-08-16       Impact factor: 8.551

7.  Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation.

Authors:  Yoshikazu Uchida; Hiroko Hama; Nathan L Alderson; Sounthala Douangpanya; Yu Wang; Debra A Crumrine; Peter M Elias; Walter M Holleran
Journal:  J Biol Chem       Date:  2007-03-12       Impact factor: 5.157

8.  Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus.

Authors:  Junko Arikawa; Mutsumi Ishibashi; Makoto Kawashima; Yutaka Takagi; Yoshiaki Ichikawa; Genji Imokawa
Journal:  J Invest Dermatol       Date:  2002-08       Impact factor: 8.551

Review 9.  Atopic dermatitis: a disease of altered skin barrier and immune dysregulation.

Authors:  Mark Boguniewicz; Donald Y M Leung
Journal:  Immunol Rev       Date:  2011-07       Impact factor: 12.988

10.  Cellular changes that accompany shedding of human corneocytes.

Authors:  Tzu-Kai Lin; Debra Crumrine; Larry D Ackerman; Juan-Luis Santiago; Truus Roelandt; Yoshikazu Uchida; Melanie Hupe; Gemma Fabriàs; Jose L Abad; Robert H Rice; Peter M Elias
Journal:  J Invest Dermatol       Date:  2012-06-28       Impact factor: 8.551

View more
  13 in total

1.  Serum Metabonomics of Mild Acute Pancreatitis.

Authors:  Hongmin Xu; Lei Zhang; Huan Kang; Jiandong Zhang; Jie Liu; Shuye Liu
Journal:  J Clin Lab Anal       Date:  2016-05-12       Impact factor: 2.352

Review 2.  Lipid abnormalities and lipid-based repair strategies in atopic dermatitis.

Authors:  Peter M Elias
Journal:  Biochim Biophys Acta       Date:  2013-10-12

3.  Sweat lipid mediator profiling: a noninvasive approach for cutaneous research.

Authors:  Karan Agrawal; Lauren A Hassoun; Negar Foolad; Theresa L Pedersen; Raja K Sivamani; John W Newman
Journal:  J Lipid Res       Date:  2016-11-08       Impact factor: 5.922

Review 4.  Molecular biology of atopic dermatitis.

Authors:  Zhanglei Mu; Yan Zhao; Xiaojing Liu; Christopher Chang; Jianzhong Zhang
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 5.  Mechanisms of abnormal lamellar body secretion and the dysfunctional skin barrier in patients with atopic dermatitis.

Authors:  Peter M Elias; Joan S Wakefield
Journal:  J Allergy Clin Immunol       Date:  2014-08-15       Impact factor: 10.793

Review 6.  The role of dihydrosphingolipids in disease.

Authors:  Ruth R Magaye; Feby Savira; Yue Hua; Darren J Kelly; Christopher Reid; Bernard Flynn; Danny Liew; Bing H Wang
Journal:  Cell Mol Life Sci       Date:  2018-12-06       Impact factor: 9.261

7.  Aging-related elevation of sphingoid bases shortens yeast chronological life span by compromising mitochondrial function.

Authors:  Jae Kyo Yi; Ruijuan Xu; Eunmi Jeong; Izolda Mileva; Jean-Philip Truman; Chih-Li Lin; Kai Wang; Justin Snider; Sally Wen; Lina M Obeid; Yusuf A Hannun; Cungui Mao
Journal:  Oncotarget       Date:  2016-04-19

8.  Effect of glycation focusing on the process of epidermal lipid synthesis in a reconstructed skin model and membrane fluidity of stratum corneum lipids.

Authors:  Mami Yokota; Hitoshi Masaki; Yuri Okano; Yoshihiro Tokudome
Journal:  Dermatoendocrinol       Date:  2017-10-04

9.  Profiling of epidermal lipids in a mouse model of dermatitis: Identification of potential biomarkers.

Authors:  Jackeline Franco; Christina Ferreira; Tiago J Paschoal Sobreira; John P Sundberg; Harm HogenEsch
Journal:  PLoS One       Date:  2018-04-26       Impact factor: 3.240

10.  Fumonisins at Doses below EU Regulatory Limits Induce Histological Alterations in Piglets.

Authors:  Chloé Terciolo; Ana Paula Bracarense; Pollyana C M C Souto; Anne-Marie Cossalter; Léonie Dopavogui; Nicolas Loiseau; Carlos A F Oliveira; Philippe Pinton; Isabelle P Oswald
Journal:  Toxins (Basel)       Date:  2019-09-19       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.